• Abriva - Dacriva

Abriva - Dacriva

0 reviews / Write a review

  • In Stock
  • Rs.11,020
  • Rs.2,800


Available Options


Name:Abriva - Dacriva
Company:CCL Pharma 
Therapeutic Segment:HEPATOLOGY
Area:Hepatitis-C

Description:

           Abriva ( Sofosbuvir 400mg ) For the treatment of chronic hepatitis C (CHC) infection as a component of a combination antiviral treatment regimen in adults.

           Dacriva ( Daclatasvir 60mg ) For the treatment of chronic hepatitis C virus (HCV) infections in adults in combination with Sofosbuvir, with or without Ribavirin.


Write a review

Note: HTML is not translated!
    Bad           Good

Tags: Abriva / Dacriva